1-9 of 9
Arielle L Langer
Close
Sort by
Journal Articles

A Structured Approach to Medical Student Education in Clinic to Improve Self-Efficacy

Arielle L Langer, Aric Parnes, Navin Kumar, Jennifer C. Kesselheim, Nora Osman
Journal: Blood
Blood (2023) 142 (Supplement 1): 2303.
https://doi.org/10.1182/blood-2023-173764
Published: 2023
Journal Articles

Association of Hemoglobin Levels with Healthcare Resource Utilization and Costs in Non-Transfusion-Dependent α- and β-Thalassemia: A Retrospective Observational Study Using Real-World Data

Arielle L Langer, Amey Rane, Louise Lombard, Keely S Gilroy, Junlong Li, Jing Zhao, Carolyn R Lew, Brian M Davis, Ryan Ross, Sujit Sheth
Journal: Blood
Blood (2023) 142 (Supplement 1): 5244.
https://doi.org/10.1182/blood-2023-189236
Published: 2023
Journal Articles

Love’s labor’s lost? Fetal vs maternal AIHA outcomes

Arielle L. Langer
Journal: Blood
Blood (2023) 141 (16): 1906–1907.
https://doi.org/10.1182/blood.2023019640
Published: 2023
Journal Articles

Clinical Burden of Alpha- and Beta-Thalassemia Compared to Matched Controls in the Real-World Setting

Arielle L. Langer, Louise Lombard, Keely Gilroy, Junlong Li, Jing Zhao, Carolyn R. Lew, Erin Bullock, Brian M Davis, Sujit Sheth
Journal: Blood
Blood (2022) 140 (Supplement 1): 5362–5364.
https://doi.org/10.1182/blood-2022-167265
Published: 2022
Journal Articles

Association of Race, Ethnicity, Age and Socioeconomic Status with Access to Virtual Visits within the Brigham & Women's Hospital Division of Hematology during the COVID-19 Pandemic

Miriam Kwarteng-Siaw, Lauren E. Merz, Siyang Ren, Donna S. Neuberg, Maureen Achebe, Jorge A. Rodriguez, Arielle L. Langer
Journal: Blood
Blood (2021) 138 (Supplement 1): 342.
https://doi.org/10.1182/blood-2021-147149
Published: 2021
Journal Articles

Team-Based Learning in Medical School Hematology Course Improves Immediate Understanding but Not Long-Term Retention

Arielle L Langer, MDMPH, Adam Binder, MD, Eileen Scigliano, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42.
https://doi.org/10.1182/blood-2020-133834
Published: 2020
Journal Articles

Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis

Camille Vanessa Edwards, MBBS, BSc, Julia Gould, BA, Arielle L Langer, MD MPH, Markus Y Mapara, MD PhD, Jai Radhakrishnan, MD, Mathew S. Maurer, MD, Shahzad Raza, MD, John G. Mears, MD, Siyang Leng, MD, Jonathan S. Wall, PhD, Andrew Eisenberger, MD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 509.
https://doi.org/10.1182/blood.V130.Suppl_1.509.509
Published: 2017
Journal Articles

Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Camille V Edwards, MD, Julia Gould, BA, Arielle L Langer, MD MPH, Markus Mapara, MD PhD, Jai Radhakrishnan, MD, Matthew S Maurer, MD, Shahzad Raza, MD, John G Mears, MD, Jonathan S Wall, PhD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2016) 128 (22): 643.
https://doi.org/10.1182/blood.V128.22.643.643
Published: 2016
Journal Articles

Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis

Arielle L Langer, MD MPH, Susanna Miao, Markus Mapara, MD PhD, Jai Radhakrishnan, MD, Mathew S. Maurer, MD, Shahzad Raza, MD, John G. Mears, MD, Alan Solomon, MD, Suzanne Lentzsch, MD PhD
Journal: Blood
Blood (2015) 126 (23): 188.
https://doi.org/10.1182/blood.V126.23.188.188
Published: 2015